Potentiating effect of 5,8,11‐eicosatrienoic acid on human platelet aggregation
- 1 April 1983
- Vol. 18 (4) , 291-294
- https://doi.org/10.1007/bf02534704
Abstract
5,8,11‐Eicosatrienoic acid (20∶3ω9), a fatty acid increased in the platelet phospholipids of man and animals fed saturated fats, was either added to human platelets simultaneously with the aggregating agents, or incorporated into the platelet phospholipids by preincubation. 20∶3ω9 markedly increased the response of platelets to all aggregating agents tested when added simultaneously with the agent, but solely to thrombin and ionophore, after incorporation into the platelet phospholipids. The potentiating effects of 20∶3ω9 on thrombin aggregation do not appear to be related to prostaglandin formation, but rather to the production of a monohydroxy derivative through the lipoxygenase pathway.This publication has 18 references indexed in Scilit:
- The role of arachidonate lipoxygenase and fatty acids during irreversible blood platelet aggregation in vitroProstaglandins and Medicine, 1981
- Selective inhibitors of platelet lipoxygenase: 4,7,10,13-icosatetraynoic acid and 5,8,11,14-henicosatetraynoic acidProstaglandins, 1981
- Dihomogammalinolenic acid (20:3ω6) is more anti-aggregatory than eicosapentaenoic (20:5ω3) in a platelet-endothelial cell mixtureProstaglandins and Medicine, 1980
- A simple and efficient method for platelet isolation from their plasmaThrombosis Research, 1980
- Effect of dietary linoleic acid deficiency on platelet aggregation and phospholipid fatty acid of ratsThrombosis Research, 1978
- Endoperoxides and thromboxanes structural determinants for platelet aggregation and vasoconstrictionBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1977
- A simple radiochemical assay of thromboxane B2, 12-hydroxyeicosatetraenoic acid (HETE) and 12-hydroxyheptadecatrienoic acid (HHT) synthetized by human plateletsClinica Chimica Acta; International Journal of Clinical Chemistry, 1977
- Dihomo-γ-linolenate suppresses platelet aggregation when administered in vitro or in vivoProstaglandins, 1974
- Abnormal fatty acid composition and human atherosclerosisPostgraduate Medical Journal, 1974
- The synthesis of 1‐14C‐arachidonate and 3‐14C‐docosa‐7,10,13,16‐tetraenoateLipids, 1971